Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy

International Journal of Cardiology

Volumn 111, Issue 3, 2006, Pages 413-422

  Hoigne Ph ^a   Attenhofer Jost, C H ^a   Duru, F ^a   Oechslin, E N ^a   Seifert, B ^a   Widmer, U ^a   Frischknecht, B ^a   Jenni, R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Amyloidosis; Fabry disease; Hypertension; Hypertrophic cardiomyopathy; Left ventricular hypertrophy

Indexed keywords

ADULT; AGED; ANHIDROSIS; ARTICLE; BIOPSY; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIASTOLE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FABRY DISEASE; FEMALE; FOLLOW UP; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART PAPILLARY MUSCLE; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; KIDNEY DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE MALFORMATION; PARAMETERS OF MEASUREMENT AND ANALYSIS; PARESTHESIA; PATIENT SELECTION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDING; SYMPTOMATOLOGY; UNIVARIATE ANALYSIS; VALVULAR HEART DISEASE;

ADULT; AGED; AMYLOIDOSIS; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FABRY DISEASE; FEMALE; HEART DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33747001761     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.08.023     Document Type: Article

References (30)

1. Beer G., Reinecke P., Gabbert H.E., Hort W., and Kuhn H. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Z Kardiol 91 12 (2002) 992-1002
2. Ommen S.R., Nishimura R.A., and Edwards W.D. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy?. Heart 89 8 (2003) 929-930
3. Sachdev B., Takenaka T., Teraguchi H., et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105 12 (2002) 1407-1411
4. Nakao S., Takenaka T., and Hea T. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 333 (1995) 288-293
5. Kampmann C., Wiethoff C.M., Perrot A., Beck M., Dietz R., and Osterziel K.J. The heart in Anderson Fabry disease. Z Kardiol 91 10 (2002) 786-795
6. Martinez M.A., Sancho T., Armada E., et al. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens 16 7 (2003) 556-563
7. Nakamura T., Sugihara H., Kinoshita N., Yoneyama S., Azuma A., and Nakagawa M. Can serum carnitine levels distinguish hypertrophic cardiomyopathy from hypertensive hearts?. Hypertension 36 2 (2000) 215-219
8. Keller H., Wanger K.C., Goepfrich M., Stegaru B., Buss J., and Heene D.L. Morphological quantification and differentiation of left ventricular hypertrophy in hypertrophic cardiomyopathy and hypertensive heart disease. A two dimensional echocardiographic study. Eur Heart J 11 1 (1990) 65-74
9. Alizad A., and Seward J.B. Echocardiographic features of genetic diseases: part 1. Cardiomyopathy. J Am Soc Echocardiogr 13 1 (2000) 73-86
10. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
11. Jenni R.V., Hess A., Anliker O., and M.Krayenbuehl H.P. Estimation of left ventricular volume from apical orthogonal two-dimensional echocardiograms. Eur Heart J 2 (1981) 217-225
12. Devereux R.B., Alonso D.R., and EMea L. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
13. Cohen G.P., Thomas J.F., and JD. Klein A.L. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 27 (1996) 1753-1760
14. Sokolow M., and Lyon T.P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 37 (1949) 161
15. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 109 (1985) 568-574
16. Sakata K., Shimizu M., Ino H., et al. QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy. Heart 89 8 (2003) 882-886
17. Maron B.J. The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited. Ann Noninvasive Electrocardiol 6 4 (2001) 277-279
18. Waldek S. PR interval and the response to enzyme-replacement therapy for Fabry's disease. N Engl J Med 348 12 (2003) 1186-1187
19. Arad M., Maron B.J., Gorham J.M., et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352 4 (2005) 362-372
20. Goldman M.E., Cantor R., Schwartz M.F., Baker M., and Desnick R.J. Echocardiographic abnormalities and disease severity in Fabry's disease. J Am Coll Cardiol 7 5 (1986) 1157-1161
21. Shapiro L.M., Kleinbenne A., and McKenna W.J. The distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: comparison to athletes and hypertensives. Eur Heart J 6 (1985) 967-974
22. Lewis J.F., and Maron B.J. Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening. Am J Cardiol 65 (1990) 874-881
23. Alfonso F., and Aragoncillo P. Anomalous papillary muscle in hypertrophic cardiomyopathy. Heart 86 1 (2001) 2
24. Colucci W.S., Lorell B.H., Schoen F.J., Warhol M.J., and Grossman W. Hypertrophic obstructive cardiomyopathy due to Fabry's disease. N Engl J Med 307 15 (1982) 926-928
25. von Scheidt W., Eng C.M., and TFea F. An atpyical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 324 (1991) 395-399
26. Linhart A., Palecek T., Bultas J., et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 139 6 (2000) 1101-1108
27. Click R.L., Olson L.J., Edwards W.D., et al. Echocardiography and systemic diseases. J Am Soc Echocardiogr 7 2 (1994) 201-216
28. Beer G., Gietzen F., Hort W., Gabbert H.E., and Kuhn H. The incidence of concealed myocardial storage disease detected by endomyocardial catheter biopsy in patients with hypertrophic non obstructive cardiomyopathy. Eur Heart J 21 Suppl A (2000) 2249
29. Pieroni M., Chimenti C., Ricci R., Sale P., Russo M.A., and Frustaci A. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 107 15 (2003) 1978-1984
30. Weidemann F., Breunig F., Beer M., et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108 11 (2003) 1299-1301